Jami Rubin's Insider Trades & SAST Disclosures
Jami Rubin's most recent trade in Boundless Bio Inc. was a trade of 196,666 Stock Option done . Disclosure was reported to the exchange on Aug. 19, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jami Rubin.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Boundless Bio Inc. | Jami Rubin | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 196,666 | 196,666 | - | - | Stock Option | |
| Boundless Bio Inc. | Jami Rubin | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Aug 2024 | 196,666 | 0 | - | - | Stock Option | |
| Boundless Bio Inc. | Jami Rubin | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 51,420 | 51,420 | - | - | Stock Option | |
| Boundless Bio Inc. | Jami Rubin | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Aug 2024 | 51,420 | 0 | - | - | Stock Option | |
| Boundless Bio Inc. | Jami Rubin | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 32,468 | 32,468 | - | - | Stock Option | |
| Boundless Bio Inc. | Jami Rubin | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Aug 2024 | 32,468 | 0 | - | - | Stock Option | |
| Relay Therapeutics Inc | Jami Rubin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2024 | 42,242 | 0 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Jami Rubin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.04 per share. | 10 Jun 2024 | 42,242 | 67,242 | - | 5.0 | 212,900 | Common Stock |
| Relay Therapeutics Inc | Jami Rubin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 102,225 | 102,225 | - | - | Stock Option (Right to Buy) | |
| Boundless Bio Inc. | Jami Rubin | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2024 | 32,468 | 32,468 | - | - | Stock Option | |
| Relay Therapeutics Inc | Jami Rubin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 66,055 | 66,055 | - | - | Stock Option (Right to Buy) | |
| EQRx Inc | Jami Rubin | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2023 | 1,585 | 302,203 | - | - | Earn-out Shares | |
| Relay Therapeutics Inc | Jami Rubin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 41,597 | 41,597 | - | - | Stock Option (Right to Buy) | |
| EQRx Inc | Jami Rubin | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 515,601 | 515,601 | - | - | Stock Option (Right to Buy) | |
| EQRx Inc | Jami Rubin | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2021 | 2,194,500 | 2,194,500 | - | - | Common Stock | |
| EQRx Inc | Jami Rubin | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2021 | 300,618 | 300,618 | - | - | Earn-out Shares | |
| Relay Therapeutics Inc | Jami Rubin | Director | Purchase of securities on an exchange or from another person at price $ 20.00 per share. | 20 Jul 2020 | 25,000 | 25,000 | - | 20 | 500,000 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges